Profil
Matthew Rosen has founded a company called Medasystems, Inc. in 2021 and currently holds the title of Director & Executive Vice President.
Aktive Positionen von Matthew Rosen
Unternehmen | Position | Beginn |
---|---|---|
Medasystems, Inc.
Medasystems, Inc. Packaged SoftwareTechnology Services Medasystems, Inc. is a software development company based in Menlo Park, CA. Medasystems specializes in developing software that streamlines the handling of requests for experimental therapies from healthcare providers. The company's secure and GXP compliant application acts as a centralized environment, connecting physicians and pharmaceutical companies to facilitate patient access to investigational therapies. The platform streamlines physician inquiries to life science companies for investigational medicine, including expanded access or compassionate use, post-trial access, and investigator-initiated studies. Medasystems provides pharmaceutical manufacturers with software and tools to streamline expanded access or compassionate use requests, as well as the evaluation of IIS or IST proposals, and the management of post-trial access. Medasystems, Inc. was founded by Jeffrey Thibeault, Matthew Rosen, and John Langlands. Fiona Smythe has been the CEO of the company since 2021. | Gründer | 01.01.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Medasystems, Inc.
Medasystems, Inc. Packaged SoftwareTechnology Services Medasystems, Inc. is a software development company based in Menlo Park, CA. Medasystems specializes in developing software that streamlines the handling of requests for experimental therapies from healthcare providers. The company's secure and GXP compliant application acts as a centralized environment, connecting physicians and pharmaceutical companies to facilitate patient access to investigational therapies. The platform streamlines physician inquiries to life science companies for investigational medicine, including expanded access or compassionate use, post-trial access, and investigator-initiated studies. Medasystems provides pharmaceutical manufacturers with software and tools to streamline expanded access or compassionate use requests, as well as the evaluation of IIS or IST proposals, and the management of post-trial access. Medasystems, Inc. was founded by Jeffrey Thibeault, Matthew Rosen, and John Langlands. Fiona Smythe has been the CEO of the company since 2021. | Technology Services |